What is "oritavancin"

n. A glycopeptide antibiotic being developed for the treatment of serious Gram-positive infections.

Oritavancin ( INN, also known as LY333328, Orbactiv) is a novel semisynthetic glycopeptide antibiotic for the treatment of serious Gram-positive bacterial infections. Its chemical structure as a lipoglycopeptide is similar to vancomycin.

In August 2014, the United States FDA approved oritavancin for treatment of skin infections.